Euclidean Technologies Management, LLC

SEC CIK: 0001597864
Latest filing: Apr 26, 2023

SEC filings (opens in a new tab)

EGRX holding history

Eagle Pharmaceuticals, Inc. in every 13F filed by Euclidean Technologies Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EGRX overview All 13F holders of EGRX Full Q1 2023 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2022

Holdings of EGRX by Euclidean Technologies Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−72,263−100.0%	Sold out	Holders
Q4 2022	72,263	$2.11M	2.0%	+10,000+16.1%	Added	Holders
Q3 2022	62,263	$1.65M	1.8%	+62,263	New	Holders